Prediction of Incident Heart Failure in Men and Women with a History of Myocardial Infarction
AIMS: Individuals with prior myocardial infarction (MI) show increased risk of heart failure (HF), yet current risk prediction models leave room for improvement. We aimed to develop and validate a clinically viable prediction model for incident HF in persons with prevalent MI in a general population, and explore sex- and MI subtype-specific differences. METHODS: We analysed UK Biobank participants with prior MI but absence of HF at baseline. Sociodemographic factors, clinical variables, and 59 blood biomarkers were included. The primary endpoint was the first in-hospital HF diagnosis. Backward selected Cox proportional hazards models were used to identify independent predictors of incident HF. Model performance was assessed via discrimination (C-index), using internal- and hold-out validation, and calibration. RESULTS: A total of 4,743 participants with prevalent MI; 81.4% male, median (P25-P75) age 62(58-66) years, were included. During a median follow-up of 12.1(11.1-13.0) years, 767(16.2%) developed HF. Sixteen independent predictors were identified and eleven remained significant (P<0.05) after treating all-cause mortality as a competing risk. These included several well-established predictors (age, body mass index, smoking, atrial fibrillation, diabetes) as well as haemoglobin (HR per 1 standard deviation (SD) increase: 0.88(95%CI:0.79-0.96)), mean reticulocyte volume (HR: (1.13(95%CI:1.03-1.23)), and neutrophil percentage (HR:1.12(95%CI:1.03-1.21)), monocyte count (HR:1.11(95%CI,1.06-1.16)). A trend towards an interaction(P<0.1) between sex and MI subtype was present. Model discrimination was modest (C-index=0.67) and calibration was adequate. CONCLUSION: Our study identifies several clinically accessible blood biomarkers as important risk factors for HF in post-MI individuals, and suggests interactions between sex and MI subtype. Further model refinement and external validation are needed.
Authors
- Navin Suthahar (ORCID: https://orcid.org/0000-0002-7781-2897)
- Isabella Kardys (ORCID: https://orcid.org/0000-0002-2115-9745)
- Phoebe Chan (ORCID: https://orcid.org/0000-0001-6582-1967)
- Eric H. Boersma (ORCID: https://orcid.org/0000-0002-2559-7128)
- Thomas Kok (ORCID: https://orcid.org/0009-0002-8772-3924)
- R Van Der Boon
- Rudolf A de Boer
Institutions
- Erasmus MC Cancer Institute (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-06-30
- DOI
- https://doi.org/10.1093/eschf/xvag187
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00